Logo

Paired Ends: Alexander Kohlmann, Jeffrey Gordon

May 06, 2014
Premium

Alexander Kohlmann is now director of bioscience at AstraZeneca. Previously, he was headed up the department of next-generation sequencing and microarrays at the Munich Leukemia Laboratory. Before that, he was research alliance manager at Roche Diagnostics.

Jeffrey Gordon, director of Washington University School of Medicine's Center for Genome Sciences and Systems Biology has won the 2014 Passano Foundation Award for his work demonstrating how gut microbes influence human health.

Gordon joined Wash U's School of Medicine in 1981. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine of the National Academies.

Filed under

Clinical Sequencing
Sequencing
Next-Generation Sequencing
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.